DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Wells Fargo Downgrades Sunesis Pharmaceuticals to Equal-Weight, Lowers Price Target to $1

Wells Fargo analyst Jim Birchenough downgrades Sunesis Pharmaceuticals (NASDAQ:SNSS) from Overweight to Equal-Weight and lowers the price target from $3 to $1.

Benzinga · 03/11/2020 11:57

Wells Fargo analyst Jim Birchenough downgrades Sunesis Pharmaceuticals (NASDAQ:SNSS) from Overweight to Equal-Weight and lowers the price target from $3 to $1.